Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Ventricle Neoplasms | 2 | 2019 | 5 | 0.850 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2019 | 5 | 0.700 |
Why?
|
| Neurocytoma | 1 | 2019 | 1 | 0.690 |
Why?
|
| Fourth Ventricle | 1 | 2019 | 1 | 0.690 |
Why?
|
| Supratentorial Neoplasms | 1 | 2019 | 3 | 0.690 |
Why?
|
| Ependymoma | 1 | 2019 | 4 | 0.690 |
Why?
|
| Ganglioglioma | 1 | 2019 | 6 | 0.690 |
Why?
|
| Death, Sudden | 1 | 2019 | 8 | 0.690 |
Why?
|
| Coordination Complexes | 2 | 2016 | 9 | 0.660 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2018 | 1 | 0.650 |
Why?
|
| Acanthamoeba | 1 | 2018 | 3 | 0.650 |
Why?
|
| Heart Transplantation | 1 | 2018 | 27 | 0.640 |
Why?
|
| Palladium | 2 | 2015 | 2 | 0.560 |
Why?
|
| Platinum | 2 | 2015 | 21 | 0.550 |
Why?
|
| Copper | 1 | 2016 | 12 | 0.530 |
Why?
|
| Molecular Structure | 8 | 2016 | 59 | 0.530 |
Why?
|
| Oxazoles | 1 | 2015 | 5 | 0.520 |
Why?
|
| Benzylidene Compounds | 1 | 2015 | 7 | 0.520 |
Why?
|
| Hydrazines | 1 | 2015 | 4 | 0.520 |
Why?
|
| Polymers | 1 | 2016 | 64 | 0.520 |
Why?
|
| Crystallography, X-Ray | 7 | 2016 | 90 | 0.460 |
Why?
|
| Pyridines | 2 | 2015 | 76 | 0.450 |
Why?
|
| Hydrogen Bonding | 5 | 2018 | 22 | 0.440 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 46 | 0.420 |
Why?
|
| Brain | 1 | 2019 | 951 | 0.410 |
Why?
|
| DNA | 2 | 2015 | 226 | 0.410 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 608 | 0.350 |
Why?
|
| Arsenates | 1 | 2007 | 1 | 0.300 |
Why?
|
| Tetraethylammonium | 1 | 2007 | 4 | 0.300 |
Why?
|
| Piperazines | 1 | 2007 | 54 | 0.290 |
Why?
|
| Carbamazepine | 1 | 2006 | 5 | 0.270 |
Why?
|
| Male | 10 | 2019 | 19165 | 0.270 |
Why?
|
| Humans | 15 | 2019 | 32005 | 0.240 |
Why?
|
| Ligands | 4 | 2019 | 81 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Models, Molecular | 5 | 2019 | 193 | 0.220 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1328 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Streptomyces | 2 | 2011 | 2 | 0.200 |
Why?
|
| Behavior, Animal | 2 | 2019 | 250 | 0.190 |
Why?
|
| Aged | 5 | 2019 | 10301 | 0.180 |
Why?
|
| Cystitis | 1 | 2019 | 8 | 0.180 |
Why?
|
| Encephalitis | 1 | 2019 | 4 | 0.180 |
Why?
|
| Neurosyphilis | 1 | 2019 | 3 | 0.180 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 38 | 0.170 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2019 | 3 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 32 | 0.170 |
Why?
|
| Retinal Hemorrhage | 1 | 2019 | 14 | 0.170 |
Why?
|
| Antibodies | 1 | 2019 | 52 | 0.170 |
Why?
|
| Affect | 1 | 2019 | 69 | 0.170 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2019 | 26 | 0.170 |
Why?
|
| Microscopy | 1 | 2019 | 26 | 0.170 |
Why?
|
| Nitro Compounds | 1 | 2019 | 4 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Optic Nerve Diseases | 1 | 2019 | 19 | 0.170 |
Why?
|
| Aneurysm, Ruptured | 1 | 2019 | 32 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 16 | 0.160 |
Why?
|
| Astrocytoma | 1 | 2019 | 29 | 0.160 |
Why?
|
| Autopsy | 1 | 2018 | 35 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2019 | 56 | 0.160 |
Why?
|
| Child, Preschool | 2 | 2019 | 1269 | 0.160 |
Why?
|
| Proline | 1 | 2018 | 12 | 0.160 |
Why?
|
| Fatal Outcome | 1 | 2018 | 83 | 0.160 |
Why?
|
| Poliovirus | 1 | 2018 | 3 | 0.160 |
Why?
|
| Rhinovirus | 1 | 2018 | 9 | 0.160 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 68 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 324 | 0.160 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 13 | 0.160 |
Why?
|
| Oncolytic Virotherapy | 1 | 2018 | 14 | 0.160 |
Why?
|
| Hippocampus | 1 | 2019 | 171 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 517 | 0.150 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 538 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2018 | 81 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 80 | 0.150 |
Why?
|
| Binding Sites | 2 | 2019 | 130 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2018 | 156 | 0.140 |
Why?
|
| Depression | 1 | 2019 | 444 | 0.130 |
Why?
|
| Ions | 1 | 2016 | 12 | 0.130 |
Why?
|
| Barbiturates | 1 | 2015 | 2 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 367 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2012 | 58 | 0.130 |
Why?
|
| Young Adult | 2 | 2019 | 2636 | 0.130 |
Why?
|
| Phospholipase D | 1 | 2014 | 4 | 0.120 |
Why?
|
| Muscle Spindles | 1 | 2014 | 5 | 0.120 |
Why?
|
| Kainic Acid | 1 | 2014 | 7 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 24 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 726 | 0.120 |
Why?
|
| Models, Chemical | 2 | 2018 | 34 | 0.120 |
Why?
|
| Animals | 6 | 2019 | 7541 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 14 | 0.110 |
Why?
|
| CHO Cells | 1 | 2012 | 24 | 0.110 |
Why?
|
| Cricetinae | 1 | 2012 | 39 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2013 | 114 | 0.100 |
Why?
|
| Molecular Conformation | 4 | 2018 | 13 | 0.100 |
Why?
|
| Macrolides | 1 | 2011 | 6 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3990 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 638 | 0.100 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 2 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 633 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 201 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2012 | 604 | 0.090 |
Why?
|
| Porifera | 1 | 2009 | 2 | 0.090 |
Why?
|
| Diterpenes | 1 | 2009 | 20 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 40 | 0.080 |
Why?
|
| Adult | 5 | 2019 | 9345 | 0.080 |
Why?
|
| Rats | 1 | 2012 | 1595 | 0.080 |
Why?
|
| Echinodermata | 1 | 2007 | 1 | 0.080 |
Why?
|
| Pyrones | 1 | 2007 | 4 | 0.080 |
Why?
|
| Dicarboxylic Acids | 1 | 2008 | 7 | 0.080 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2008 | 21 | 0.080 |
Why?
|
| Naphthalenes | 1 | 2007 | 40 | 0.080 |
Why?
|
| Octanes | 1 | 2007 | 1 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2007 | 81 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2008 | 220 | 0.070 |
Why?
|
| Crystallization | 1 | 2006 | 17 | 0.070 |
Why?
|
| Female | 5 | 2019 | 19959 | 0.060 |
Why?
|
| Stereoisomerism | 2 | 2018 | 22 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 898 | 0.060 |
Why?
|
| Middle Aged | 3 | 2018 | 11817 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2011 | 87 | 0.050 |
Why?
|
| Mice | 2 | 2019 | 2484 | 0.050 |
Why?
|
| Glyburide | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mesna | 1 | 2019 | 3 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2019 | 16 | 0.040 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 12 | 0.040 |
Why?
|
| Forensic Pathology | 1 | 2019 | 11 | 0.040 |
Why?
|
| Brain Death | 1 | 2019 | 26 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 48 | 0.040 |
Why?
|
| Isomerism | 1 | 2019 | 7 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 74 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2019 | 12 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 57 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 11 | 0.040 |
Why?
|
| Drug Design | 1 | 2019 | 43 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 46 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2019 | 100 | 0.040 |
Why?
|
| Neuralgia | 1 | 2019 | 48 | 0.040 |
Why?
|
| Infusions, Intralesional | 1 | 2018 | 2 | 0.040 |
Why?
|
| Chimera | 1 | 2018 | 10 | 0.040 |
Why?
|
| Protein Binding | 1 | 2018 | 201 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 743 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 767 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 682 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1022 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 877 | 0.030 |
Why?
|
| Picrates | 1 | 2015 | 1 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2015 | 3 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2015 | 2 | 0.030 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2015 | 3 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 19 | 0.030 |
Why?
|
| Plasmids | 1 | 2015 | 48 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 69 | 0.030 |
Why?
|
| Antioxidants | 1 | 2015 | 115 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 284 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 261 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 322 | 0.030 |
Why?
|
| Vibrio | 1 | 2011 | 1 | 0.020 |
Why?
|
| Hygromycin B | 1 | 2011 | 2 | 0.020 |
Why?
|
| Cinnamates | 1 | 2011 | 3 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2011 | 3 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2011 | 9 | 0.020 |
Why?
|
| Hydro-Lyases | 1 | 2011 | 1 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 13 | 0.020 |
Why?
|
| Metabolome | 1 | 2011 | 36 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 80 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 53 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 33 | 0.020 |
Why?
|
| Marine Biology | 1 | 2009 | 1 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 5 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 20 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 4 | 0.020 |
Why?
|
| Fiji | 1 | 2007 | 1 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 8 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 252 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 210 | 0.020 |
Why?
|